Abstract
AbstractThe discourse amongst diabetes specialists and academics regarding technology and artificial intelligence (AI) typically centres around the 10% of people with diabetes who have type 1 diabetes, focusing on glucose sensors, insulin pumps and, increasingly, closed-loop systems. This focus is reflected in conference topics, strategy documents, technology appraisals and funding streams. What is often overlooked is the wider application of data and AI, as demonstrated through published literature and emerging marketplace products, that offers promising avenues for enhanced clinical care, health-service efficiency and cost-effectiveness. This review provides an overview of AI techniques and explores the use and potential of AI and data-driven systems in a broad context, covering all diabetes types, encompassing: (1) patient education and self-management; (2) clinical decision support systems and predictive analytics, including diagnostic support, treatment and screening advice, complications prediction; and (3) the use of multimodal data, such as imaging or genetic data. The review provides a perspective on how data- and AI-driven systems could transform diabetes care in the coming years and how they could be integrated into daily clinical practice. We discuss evidence for benefits and potential harms, and consider existing barriers to scalable adoption, including challenges related to data availability and exchange, health inequality, clinician hesitancy and regulation. Stakeholders, including clinicians, academics, commissioners, policymakers and those with lived experience, must proactively collaborate to realise the potential benefits that AI-supported diabetes care could bring, whilst mitigating risk and navigating the challenges along the way.
Graphical Abstract
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference77 articles.
1. International Diabetes Federation (2022) IDF Diabetes Atlas. 10th ed. Available from: http://www.diabetesatlas.org/. Accessed: 13 April 2023
2. Chung WK, Erion K, Florez JC et al (2020) Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 63:1671–1693. https://doi.org/10.1007/s00125-020-05181-w
3. Contreras I, Vehi J (2018) Artificial intelligence for diabetes management and decision support: literature review. J Med Internet Res 20(5):e10775. https://doi.org/10.2196/10775
4. NHS (2023) Artificial intelligence (AI) funding streams. Available from: https://transform.england.nhs.uk/ai-lab/explore-all-resources/understand-ai/artificial-intelligence-ai-funding-streams/. Accessed: 30 September 2023
5. European Commission (2021) Science for policy brief: how can Europe become a global leader in AI in health? Available from: https://ai-watch.ec.europa.eu/publications/science-policy-brief-how-can-europe-become-global-leader-ai-health_en. Accessed: 24 April 2023